Article
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Cancer gene therapy - 1 Jan 2000
Harris M P, Sutjipto S, Wills K N, Hancock W, Cornell D, Johnson D E, Gregory R J, Shepard H M, Maneval D C
Abstract excerpt
Human malignancies are often characterized by mutations of the p53 tumor suppressor gene. In a large proportion of cases, the mutation results in production of an altered protein that can bind and inactivate the wild-type gene product. This "dominant-negative" activity of mutant p53 molecules may limit the utility of p53 gene therapy of cancer. Using replication-deficient recombinant adenoviruses (rAd-p53) as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
